MS
Mamata Singh
About Mamata Singh
Data last updated:
Mamata Singh is a Director at Jvin Pharma Private Limited (since 2024) and Director at Narcico Private Limited (since 2024). The companies operate in Business Services and Paper. The largest current company by reported revenue is Jvin Pharma Private Limited at ₹52.8 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 May 2024 | 2019 | ₹52.8 Lakh (FY 2025) | Active | |
| Director | 02 Aug 2024 | 2024 | Active |
Board colleagues of Mamata Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Kumar Singh | 08568309 | Jvin Pharma Private Limited , Narcico Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mamata Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mamata Singh
Mamata Singh currently holds 2 directorships: Jvin Pharma Private Limited (Director, since 16 May 2024, revenue ₹52.8 Lakh (FY 2025)); Narcico Private Limited (Director, since 02 Aug 2024).
Mamata Singh was first appointed on 16 May 2024 as Director at Jvin Pharma Private Limited.
The current boards of Mamata Singh's companies include Amit Kumar Singh (Jvin Pharma Private Limited).